Clotrimazole and betamethasone dipropionate and Glipizide drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Clotrimazole and betamethasone dipropionate and Glipizide. Common interactions include chronic kidney disease among females and arteriovenous fistula occlusion among males.

The phase IV clinical study analyzes what interactions people who take Clotrimazole and betamethasone dipropionate and Glipizide have. It is created by eHealthMe based on reports of 27 people who take Clotrimazole and betamethasone dipropionate and Glipizide from the FDA, and is updated regularly. You can use the study as a second opinion to make health care decisions.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.



On Oct, 03, 2022

27 people who take Clotrimazole and betamethasone dipropionate and Glipizide together, and have interactions are studied.


What is Clotrimazole and betamethasone dipropionate?

Clotrimazole and betamethasone dipropionate has active ingredients of betamethasone dipropionate; clotrimazole. eHealthMe is studying from 463 Clotrimazole and betamethasone dipropionate users for its effectiveness, alternative drugs and more.

What is Glipizide?

Glipizide has active ingredients of glipizide. It is often used in diabetes. eHealthMe is studying from 60,242 Glipizide users for its effectiveness, alternative drugs and more.

Number of Clotrimazole and betamethasone dipropionate and Glipizide reports submitted per year:

Clotrimazole and betamethasone dipropionate and Glipizide drug interactions.

Common Clotrimazole And Betamethasone Dipropionate and Glipizide drug interactions by gender *:

female:

  1. Chronic kidney disease
  2. Oedema peripheral
  3. Pain in extremity
  4. Hyperparathyroidism secondary
  5. Renal failure
  6. Abdominal discomfort
  7. Back pain
  8. Blood glucose fluctuation
  9. Blood potassium increased
  10. Blood pressure decreased

male:

  1. Arteriovenous fistula occlusion
  2. Chronic kidney disease
  3. Abscess
  4. Abscess limb
  5. Ageusia
  6. Anal abscess
  7. Brain herniation
  8. Cellulitis
  9. Cerebral haemorrhage
  10. Chills

Common Clotrimazole And Betamethasone Dipropionate and Glipizide drug interactions by age *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

  1. Abscess
  2. Abscess limb
  3. Anal abscess
  4. Cellulitis
  5. Gangrene
  6. Perirectal abscess
  7. Sepsis
  8. Soft tissue necrosis
  9. Subcutaneous abscess
  10. Urinary tract infection

40-49:

  1. Chronic kidney disease
  2. Renal failure
  3. Weight decreased

50-59:

  1. Anaemia
  2. Renal failure
  3. Arteriovenous fistula occlusion
  4. Chronic kidney disease
  5. Dyspnoea
  6. Back pain
  7. Blood glucose fluctuation
  8. Blood potassium increased
  9. Blood pressure decreased
  10. Colon cancer recurrent

60+:

  1. Arteriovenous fistula occlusion
  2. Chronic kidney disease
  3. Ageusia
  4. Brain herniation
  5. Cerebral haemorrhage
  6. Chills
  7. Constipation
  8. Cystitis
  9. Death
  10. Decreased appetite

Common conditions people have *:

  1. Multiple Myeloma (cancer of the plasma cells): 9 people, 33.33%
  2. High Blood Pressure: 7 people, 25.93%
  3. Infection: 5 people, 18.52%
  4. High Blood Cholesterol: 5 people, 18.52%
  5. Pain: 4 people, 14.81%
  6. Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 4 people, 14.81%
  7. Type 2 Diabetes: 3 people, 11.11%
  8. Fluid Retention (an abnormal accumulation of fluid in the blood): 3 people, 11.11%
  9. General Physical Health Deterioration (weak health status): 3 people, 11.11%
  10. Hypovitaminosis (any of several diseases caused by deficiency of one or more vitamins): 3 people, 11.11%

* Approximation only. Some reports may have incomplete information.

Do you take Clotrimazole and betamethasone dipropionate and Glipizide?

Personalize this study to your gender and age

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.



Related publications that referenced our studies

Related studies

Alternative drugs to, pros and cons of the 2 drugs:

Browse all drug interactions of Clotrimazole and betamethasone dipropionate and Glipizide:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Common Clotrimazole and betamethasone dipropionate interactions:

Browse all interactions between Clotrimazole and betamethasone dipropionate and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Common Glipizide interactions:

Browse all interactions between Glipizide and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on betamethasone dipropionate; clotrimazole and glipizide (the active ingredients of Clotrimazole and betamethasone dipropionate and Glipizide, respectively), and Clotrimazole and betamethasone dipropionate and Glipizide (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study. Patients in the study may take other drugs besides Clotrimazole and betamethasone dipropionate and Glipizide.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe: